NTV Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
NTV Asset Management's ARKG Position: Q3 2026 in Review
NTV Asset Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.7% in Q3 2026, selling an estimated $78.3K and leaving 246,758 shares worth $13.4M. The position accounts for 1.24% of the portfolio, ranked #14.
NTV Asset Management first reported a position in ARKG in Q3 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- NTV Asset Management held 246,758 shares of ARK Genomic Revolution ETF worth $13.4M as of Q3 2026.
- NTV Asset Management sold 1,742 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $78.3K.
- ARK Genomic Revolution ETF made up 1.24% of NTV Asset Management's portfolio in Q3 2026, its #14 holding.
- NTV Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 5 quarters since.
- 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on NTV Asset Management's 13F filing for Q3 2026, filed 23 Oct 2026.